135 related articles for article (PubMed ID: 27997582)
1. (GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.
Køllgaard T; Kornblit B; Petersen J; Klausen TW; Mortensen BK; Brændstrup P; Sengeløv H; Høgdall E; Müller K; Vindeløv L; Andersen MH; Thor Straten P
PLoS One; 2016; 11(12):e0168210. PubMed ID: 27997582
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.
Gerbitz A; Hillemanns P; Schmid C; Wilke A; Jayaraman R; Kolb HJ; Eissner G; Holler E
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1180-1189. PubMed ID: 18804049
[TBL] [Abstract][Full Text] [Related]
4. Association between the heme oxygenase-1 promoter polymorphism and renal transplantation outcome in Greece.
Katana E; Skoura L; Giakoustidis D; Takoudas D; Malisiovas N; Daniilidis M
Transplant Proc; 2010 Sep; 42(7):2479-85. PubMed ID: 20832528
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.
Gill AJ; Garza R; Ambegaokar SS; Gelman BB; Kolson DL
J Neuroinflammation; 2018 Mar; 15(1):70. PubMed ID: 29510721
[TBL] [Abstract][Full Text] [Related]
6. Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.
Spilleboudt C; De Wilde V; Lewalle P; Cabanne L; Leclerc M; Beckerich F; Bories D; Cardoso S; Soares MP; Vokaer B; Hougardy JM; Flamand V; Racapé J; Abramowicz M; Maury S; Le Moine A
Front Immunol; 2020; 11():579151. PubMed ID: 33537027
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
9. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan.
Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ
Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634
[TBL] [Abstract][Full Text] [Related]
10. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.
Lin CC; Yang WC; Lin SJ; Chen TW; Lee WS; Chang CF; Lee PC; Lee SD; Su TS; Fann CS; Chung MY
Kidney Int; 2006 Jan; 69(1):165-72. PubMed ID: 16374439
[TBL] [Abstract][Full Text] [Related]
11. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
12. The recipient's heme oxygenase-1 promoter region polymorphism is associated with cardiac allograft vasculopathy.
Freystaetter K; Andreas M; Bilban M; Perkmann T; Kaider A; Masetti M; Kocher A; Wolzt M; Zuckermann A
Transpl Int; 2017 May; 30(5):510-518. PubMed ID: 28186648
[TBL] [Abstract][Full Text] [Related]
13. Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.
Kornblit B; Masmas T; Petersen SL; Madsen HO; Heilmann C; Schejbel L; Sengeløv H; Müller K; Garred P; Vindeløv L
Biol Blood Marrow Transplant; 2010 Feb; 16(2):239-52. PubMed ID: 19819342
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting.
Chen YH; Chau LY; Lin MW; Chen LC; Yo MH; Chen JW; Lin SJ
Eur Heart J; 2004 Jan; 25(1):39-47. PubMed ID: 14683741
[TBL] [Abstract][Full Text] [Related]
15. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Baron F; Maris MB; Sandmaier BM; Storer BE; Sorror M; Diaconescu R; Woolfrey AE; Chauncey TR; Flowers ME; Mielcarek M; Maloney DG; Storb R
J Clin Oncol; 2005 Mar; 23(9):1993-2003. PubMed ID: 15774790
[TBL] [Abstract][Full Text] [Related]
17. Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: an observation based on arsenic-exposed individuals.
Wu MM; Chiou HY; Chen CL; Hsu LI; Lien LM; Wang CH; Hsieh YC; Wang YH; Hsueh YM; Lee TC; Cheng WF; Chen CJ
Atherosclerosis; 2011 Dec; 219(2):704-8. PubMed ID: 21945498
[TBL] [Abstract][Full Text] [Related]
18. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes.
Courtney AE; McNamee PT; Middleton D; Heggarty S; Patterson CC; Maxwell AP
Am J Transplant; 2007 Apr; 7(4):908-13. PubMed ID: 17391133
[TBL] [Abstract][Full Text] [Related]
19. Donor heme oxygenase-1 genotype is associated with renal allograft function.
Exner M; Böhmig GA; Schillinger M; Regele H; Watschinger B; Hörl WH; Raith M; Mannhalter C; Wagner OF
Transplantation; 2004 Feb; 77(4):538-42. PubMed ID: 15084931
[TBL] [Abstract][Full Text] [Related]
20. HMOX1 promoter (GT)n polymorphim is associated with childhood-onset systemic lupus erythematosus but not with juvenile rheumatoid arthritis in a Mexican population.
Córdova EJ; Martínez-Hernández A; Ramírez-Bello J; Velázquez-Cruz R; Centeno F; Baca V; Orozco L
Clin Exp Rheumatol; 2012; 30(2):297-301. PubMed ID: 22338608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
